1-3 of 3
Geetika Srivastava
Close
Sort by
Journal Articles

Long Term Response To Lenalidomide With and Without Continuous Therapy Among Patients With Newly Diagnosed Multiple Myeloma

Taxiarchis Kourelis, MD, Shaji K Kumar, MD, Geetika Srivastava, MBBS, Morie A Gertz, MD, MACP, Martha Q Lacy, MD, Francis K Buadi, MD, Suzanne R Hayman, MD, Steven R Zeldenrust, MD, PhD, Nelson Leung, MD, Robert Kyle, MD, MACP, Stephen Russell, David Dingli, M.D., Ph.D., John A Lust, MD, PhD, Yi Lin, MDPhD, Prashant Kapoor, MD, Arleigh McCurdy, MD, Vincent Rajkumar, MD, Angela Dispenzieri, MD
Journal: Blood
Blood (2013) 122 (21): 3209.
https://doi.org/10.1182/blood.V122.21.3209.3209
Published: 2013
Journal Articles

Factors Predicting Early Mortality in Patients with Newly Diagnosed Multiple Myeloma,

Vishal Rana, MBBS, Geetika Srivastava, MBBS, Suzanne R Hayman, MD, Francis K Buadi, M.D., Morie A Gertz, MD, Martha Q Lacy, MD, Philip R. Greipp, MD, Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Robert A Kyle, MD, John A Lust, MD, PhD, Kristen Detweiler Short, N.P, David Dingli, M.D., Ph.D., Stephen J. Russell, S. Vincent Rajkumar, Shaji Kumar, MD
Journal: Blood
Blood (2011) 118 (21): 3981.
https://doi.org/10.1182/blood.V118.21.3981.3981
Published: 2011
Journal Articles

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

Brief Report
Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby, Mauricio Pineda-Roman, Klaus Hollmig, Yazan Alsayed, Antje Hoering, Jackie Szymonifka, Elias Anaissie, Nathan Petty, Naveen S. Kumar, Geetika Srivastava, Bonnie Jenkins, John Crowley, Jerome B. Zeldis
Journal: Blood
Blood (2008) 112 (8): 3122–3125.
https://doi.org/10.1182/blood-2008-06-164228
Published: 2008